GLP-1 medications may may cause serious side effects
The prevalence of obesity is expected to increase from 11% to 18% from 2010 to 2030 [4] paralleling diabetes trends
What is it
When selenium is reduced, some selenoproteins in the body quickly disappear (low grades), while others can continue to be synthesized even when selenium levels are reduced (high grades) ( GPX2 was the first selenoprotein identified as a target of the Wnt pathway, and its promoter contains five -catenin/TCF binding sites (TBE) (Yu et al., 2021)
However, since the tubular reabsorption occurs via an active transporter, once the transporter is saturated by the high plasma L-carnitine concentrations achieved by intravenous administration, the circulating L-carnitine is rapidly excreted
however, larger, controlled clinical trials are necessary to validate these findings and establish standardized treatment protocols